0

Nogo-66(1-40) antagonist peptide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR42414850
MDL NumberMFCD06411437
Molecular Weight4583.08 (free base basis)
Description≥84% (HPLC)
SolubilityH2O: 1 mg/mL
Assay≥84% (HPLC)
Colorwhite
Formsolid
Size1MG
Storage Conditions−20°C
1

Delayed Systemic Nogo-66 Receptor Antagonist Promotes Recovery From Spinal Cord Injury

Shuxin Li, Stephen M Strittmatter

J Neurosci. 2003 May 15;23(10):4219-27.

PMID: 12764110

1

Neuropsychiatric Involvement in Lupus Is Associated With the Nogo-a/NgR1 Pathway

Hong-Wei Lei, Jing-Yuan Wang, Qiu-Jie Dang, Fan Yang, Xin Liu, Ji-Hui Zhang, Yang Li

J Neuroimmunol. 2017 Oct 15;311:22-28.

PMID: 28807492

1

Nogo Presence Is Inversely Associated With Shifts in Cortical Microglial Morphology Following Experimental Diffuse Brain Injury

Jenna M Ziebell, Helen Ray-Jones, Jonathan Lifshitz

Neuroscience. 2017 Sep 17;359:209-223.

PMID: 28736137

1

Nogo-66 Receptor Antagonist Peptide Promotes Axonal Regeneration

Tadzia GrandPré, Shuxin Li, Stephen M Strittmatter

Nature. 2002 May 30;417(6888):547-51.

PMID: 12037567

1

The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation Through the Regulation of Microglial Inflammatory Activation

Yinquan Fang, Jun Yan, Chenhui Li, Xiao Zhou, Lemeng Yao, Tao Pang, Ming Yan, Luyong Zhang, Lei Mao, Hong Liao

J Biol Chem. 2015 Nov 27;290(48):28901-14.

PMID: 26472924

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode